Download eBook for Free

FormatFile SizeNotes
PDF file 4.1 MB

Use Adobe Acrobat Reader version 10 or higher for the best experience.

Medical providers in primary care settings can play an important role in treating patients who have a substance use problem. FDA-approved medications are now available for primary care doctors in their offices to treat appropriate patients. The addition of these medications to a standard drug or alcohol counseling program or self-help program may improve outcomes over counseling or support alone. This guide is divided into three parts: Part I reviews the approach that primary care providers should take in discussing alcohol or opioid dependence with their patients. Part II is a step-by-step guide to treating alcohol-dependent patients with extended-release, injectable naltrexone in primary care settings. Part III is a reference guide for primary care practitioners administering buprenorphine/naloxone to patients with opioid dependence.

Table of Contents

  • Part I

    Introduction to Medication-Assisted Treatment of Alcohol or Opioid Dependence in Primary Care

  • Part II

    Administering Extended-Release, Injectable Naltrexone for Patients with Alcohol Dependence: A Step-by-Step Guide for Primary Care Practitioners

    • Section One

      Quick Guide for Administering Extended-Release, Injectable Naltrexone

    • Section Two

      Determining Patient Appropriateness for Treatment with Extended-Release, Injectable Naltrexone: Visit 1

    • Section Three

      Administering Extended-Release, Injectable Naltrexone: Visit 1 or 2

    • Section Four

      Assessing Treatment Progress and Adverse Events and Administering Medication, If Appropriate: Follow-Up Visits

    • Appendix A

      Pre-Injection Checklist for Appropriateness for Extended-Release, Injectable Naltrexone

    • Appendix B

      Introduction to the Risks of Extended-Release, Injectable Naltrexone Worksheet (English and Spanish Versions)

    • Appendix C

      Step-By-Step Instructions for the Preparation and Injection of Extended Release, Injectable Naltrexone

    • Appendix D

      Follow-Up Visit Pre-Injection Checklists

    • Appendix E

      DSM-IV Alcohol Dependence Diagnosis Worksheet

    • Appendix F

      CIWA-Ar Worksheet

    • Appendix G

      Wallet Cards

    • Appendix H

      Local Referral Resources

  • Part III

    Administering Buprenorphine/Naloxone to Patients with Opioid Dependence: A Quick Reference Guide for Primary Care Practitioners

Research conducted by

The research described in this report was sponsored by the National Institute on Drug Abuse and conducted by RAND Health.

This report is part of the RAND Corporation tool series. RAND tools may include models, databases, calculators, computer code, GIS mapping tools, practitioner guidelines, web applications, and various toolkits. All RAND tools undergo rigorous peer review to ensure both high data standards and appropriate methodology in keeping with RAND's commitment to quality and objectivity.

Permission is given to duplicate this electronic document for personal use only, as long as it is unaltered and complete. Copies may not be duplicated for commercial purposes. Unauthorized posting of RAND PDFs to a non-RAND Web site is prohibited. RAND PDFs are protected under copyright law. For information on reprint and linking permissions, please visit the RAND Permissions page.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.